Arriola E - Search Results

1

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines.

Arriola E, Marchio C, Tan DS, Drury SC, Lambros MB, Natrajan R, Rodriguez-Pinilla SM, Mackay A, Tamber N, Fenwick K, Jones C, Dowsett M, Ashworth A, Reis-Filho JS. Arriola E, et al. Lab Invest. 2008 May;88(5):491-503. doi: 10.1038/labinvest.2008.19. Epub 2008 Mar 10. Lab Invest. 2008. PMID: 18332872 Free article.

2

MYC amplification in breast cancer: a chromogenic in situ hybridisation study.

Rodriguez-Pinilla SM, Jones RL, Lambros MB, Arriola E, Savage K, James M, Pinder SE, Reis-Filho JS. Rodriguez-Pinilla SM, et al. Among authors: arriola e. J Clin Pathol. 2007 Sep;60(9):1017-23. doi: 10.1136/jcp.2006.043869. Epub 2006 Dec 8. J Clin Pathol. 2007. PMID: 17158641 Free PMC article.

3

Evaluation of Phi29-based whole-genome amplification for microarray-based comparative genomic hybridisation.

Arriola E, Lambros MB, Jones C, Dexter T, Mackay A, Tan DS, Tamber N, Fenwick K, Ashworth A, Dowsett M, Reis-Filho JS. Arriola E, et al. Lab Invest. 2007 Jan;87(1):75-83. doi: 10.1038/labinvest.3700495. Lab Invest. 2007. PMID: 17170740 Free article.

4

Topoisomerase II alpha amplification may predict benefit from adjuvant anthracyclines in HER2 positive early breast cancer.

Arriola E, Rodriguez-Pinilla SM, Lambros MB, Jones RL, James M, Savage K, Smith IE, Dowsett M, Reis-Filho JS. Arriola E, et al. Breast Cancer Res Treat. 2007 Dec;106(2):181-9. doi: 10.1007/s10549-006-9492-5. Epub 2007 Jan 27. Breast Cancer Res Treat. 2007. PMID: 17260090

5

Aromatase inhibitors and male breast cancer.

Arriola E, Hui E, Dowsett M, Smith IE. Arriola E, et al. Clin Transl Oncol. 2007 Mar;9(3):192-4. doi: 10.1007/s12094-007-0034-3. Clin Transl Oncol. 2007. PMID: 17403631

6

Predictive value of HER-2 and Topoisomerase IIalpha in response to primary doxorubicin in breast cancer.

Arriola E, Moreno A, Varela M, Serra JM, Falo C, Benito E, Escobedo AP. Arriola E, et al. Eur J Cancer. 2006 Nov;42(17):2954-60. doi: 10.1016/j.ejca.2006.06.013. Epub 2006 Aug 28. Eur J Cancer. 2006. PMID: 16935488

7

Cytogenetic characterization of NCI-H69 and NCI-H69AR small cell lung cancer cell lines by spectral karyotyping.

Salido M, Arriola E, Carracedo A, Cañadas I, Rovira A, Espinet B, Rojo F, Arumi M, Serrano S, Albanell J, Sole F. Salido M, et al. Among authors: arriola e. Cancer Genet Cytogenet. 2009 Jun;191(2):97-101. doi: 10.1016/j.cancergencyto.2009.01.016. Cancer Genet Cytogenet. 2009. PMID: 19446745

8

ROS1 copy number alterations are frequent in non-small cell lung cancer.

Clavé S, Gimeno J, Muñoz-Mármol AM, Vidal J, Reguart N, Carcereny E, Pijuan L, Menéndez S, Taus Á, Mate JL, Serrano S, Albanell J, Espinet B, Arriola E, Salido M. Clavé S, et al. Among authors: arriola e. Oncotarget. 2016 Feb 16;7(7):8019-28. doi: 10.18632/oncotarget.6921. Oncotarget. 2016. PMID: 26783962 Free PMC article.

9

Apoptosis and cancer chemotherapy.

Chresta CM, Arriola EL, Hickman JA. Chresta CM, et al. Among authors: arriola el. Behring Inst Mitt. 1996 Oct;(97):232-40. Behring Inst Mitt. 1996. PMID: 8950479 Review.

10

Is there a role for epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor wild-type non-small cell lung cancer?

Arriola E, Taus Á, Casadevall D. Arriola E, et al. World J Clin Oncol. 2015 Aug 10;6(4):45-56. doi: 10.5306/wjco.v6.i4.45. World J Clin Oncol. 2015. PMID: 26266101 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

118 results

Search Page